Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma

Study Type – Therapy (cohort)

[1]  C. Dinney,et al.  Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. , 2011, Urology.

[2]  F. Brimo,et al.  Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor , 2010, World journal of surgical oncology.

[3]  Y. Matsuno,et al.  Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  F. Montorsi,et al.  Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. , 2010, The Journal of urology.

[5]  J. Richie,et al.  Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data , 2010, BJU international.

[6]  F. Montorsi,et al.  A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. , 2010, Urology.

[7]  K. Bensalah,et al.  Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. , 2009, The Journal of urology.

[8]  B. Ljungberg.  Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881 , 2009 .

[9]  P. Russo.  Radical nephrectomy with and without lymph node dissection: Final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881 , 2009 .

[10]  U. Capitanio,et al.  Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. , 2008, European urology.

[11]  M. Brausi,et al.  Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. , 2007, European urology.

[12]  F. Ito,et al.  Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. , 2007, The Journal of urology.

[13]  A. Mottrie,et al.  Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: results of a Belgian retrospective multicentre survey. , 2007, European urology.

[14]  A. Vickers,et al.  Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer , 2007, International journal of urology : official journal of the Japanese Urological Association.

[15]  C. Wood,et al.  Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. , 2006, The Journal of urology.

[16]  S. Matin.  Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status , 2005, BJU international.

[17]  J. Rassweiler,et al.  Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? , 2004, European urology.

[18]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[19]  M. Ghoneim,et al.  Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. , 2004, The Journal of urology.

[20]  S. Kropf,et al.  Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. , 2004, The Journal of urology.

[21]  Badrinath R Konety,et al.  Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. , 2003, The Journal of urology.

[22]  H. Herr,et al.  Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. , 2001, The Journal of urology.

[23]  R. Mirimanoff,et al.  Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. , 1999, European journal of cancer.

[24]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[25]  H. Miyake,et al.  The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. , 1998, British journal of urology.

[26]  F. Mostofi,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.

[27]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[28]  S. Kubodera,et al.  The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. , 1997, The Journal of urology.

[29]  M. Blute,et al.  Platinum-Chemotherapy for Advanced Transitional Cell Carcinoma of the Upper Urinary Tract , 1996 .

[30]  H. Zincke,et al.  Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract. , 1996, Mayo Clinic proceedings.

[31]  J. Baniel,et al.  Original Articles: Testis Cancer: Complications of Post-Chemotherapy Retroperitoneal Lymph Node Dissection , 1995 .

[32]  J. Baniel,et al.  Complications of post-chemotherapy retroperitoneal lymph node dissection. , 1995, The Journal of urology.